1. THU0262 Off-Label Use of Rituximab for SLE in Europe: A Comparison to Patients Treated with Conventional Immunosuppressive Medications. (23rd January 2014) Authors: van Vollenhoven, R. F.; Mild, M.; Dörner, T.; Gremese, E.; Houssiau, F.; Huizinga, T.; Isenberg, D. A.; Kovács, L.; Ruiz-Irastorza, G.; Squatrito, D.; Emmi, L.; Voskuyl, A.; Mosca, M.; Castro, A.; Iuliano, A.; Inanc, M.; Szücs, G.; Doria, A.; Jacobsen, S. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0283 Two Year Follow-Up on Biologics Use in 13 Centers - Data from the International Registry for Biologics in SLE (IRBIS). (23rd January 2014) Authors: van Vollenhoven, R.; Mild, M.; Jacobsen, S.; Wallace, D. J.; Hanley, J. G.; Petri, M. A.; Bernatsky, S. R.; Bae, S.-C.; Ramos-Casals, M.; Garcia-Hernandez, F.; Ayala-Guiterrez, M. D. M.; Ramsey-Goldman, R.; Doria, A.; Mosca, M. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗